Cite
MLA Citation
N. Kawagishi et al.. “Comparing the risk of hepatitis B virus reactivation between direct‐acting antiviral therapies and interferon‐based therapies for hepatitis C.” Journal of viral hepatitis, vol. 24, no. 12, 2017, pp. 1098–1106. http://access.bl.uk/ark:/81055/vdc_100054254545.0x00001a